1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Cardiovascular Devices Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Cardiovascular Devices Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Prevalence of Cardiovascular Diseases owing tosedentary lifestyle to propel the market growth
5.2 Market Opportunities
- 5.2.1 Emergence of resourceful start-ups in advanced cardiovascular devices space to provide room for significant opportunities
5.3 Future Trends
- 5.3.1 Persistent Technological Advancements in cardiovascular devices to augment the uptake
5.4 Impact of Drivers and Restraints
6. North America Cardiovascular Devices Market Regional Analysis
6.1 North America Cardiovascular Devices Market Overview
6.2 North America Cardiovascular Devices Market Revenue 2019-2028 (US$ Million)
6.3 North America Cardiovascular Devices Market Forecast Analysis
7. North America Cardiovascular Devices Market Analysis – by Device
7.1 Electrocardiography
- 7.1.1 Overview
- 7.1.2 Electrocardiography: North America Cardiovascular Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Pacemaker
- 7.2.1 Overview
- 7.2.2 Pacemaker: North America Cardiovascular Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Stent
- 7.3.1 Overview
- 7.3.2 Stent: North America Cardiovascular Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Defibrillator
- 7.4.1 Overview
- 7.4.2 Defibrillator: North America Cardiovascular Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Cardiac Catheter
- 7.5.1 Overview
- 7.5.2 Cardiac Catheter: North America Cardiovascular Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Guidewire
- 7.6.1 Overview
- 7.6.2 Guidewire: North America Cardiovascular Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Heart Valve
- 7.7.1 Overview
- 7.7.2 Heart Valve: North America Cardiovascular Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Event Monitor
- 7.8.1 Overview
- 7.8.2 Event Monitor: North America Cardiovascular Devices Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Cardiovascular Devices Market Analysis – by Application
8.1 Coronary Heart Disease
- 8.1.1 Overview
- 8.1.2 Coronary Heart Disease: North America Cardiovascular Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Sudden Cardiac Arrest
- 8.2.1 Overview
- 8.2.2 Sudden Cardiac Arrest: North America Cardiovascular Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Stroke
- 8.3.1 Overview
- 8.3.2 Stroke: North America Cardiovascular Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Cerebrovascular Heart Disease
- 8.4.1 Overview
- 8.4.2 Cerebrovascular Heart Disease: North America Cardiovascular Devices Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Cardiovascular Devices Market Analysis – by End-User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Cerebrovascular Heart Disease: North America Cardiovascular Devices Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Ambulatory Surgery Centers
- 9.2.1 Overview
- 9.2.2 Cerebrovascular Heart Disease: North America Cardiovascular Devices Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Cardiac Centers
- 9.3.1 Overview
- 9.3.2 Cerebrovascular Heart Disease: North America Cardiovascular Devices Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Cardiovascular Devices Market – North America Analysis
10.1 North America
- 10.1.1 North America Cardiovascular Devices Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.1.1.1 North America Cardiovascular Devices Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Cardiovascular Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 US: North America Cardiovascular Devices Market Breakdown, by Device
- 10.1.1.1.2 US: North America Cardiovascular Devices Market Breakdown, by Application
- 10.1.1.1.3 US: North America Cardiovascular Devices Market Breakdown, by End-User
- 10.1.1.2 Canada:
North America Cardiovascular Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Canada: North America Cardiovascular Devices Market Breakdown, by Device
- 10.1.1.2.2 Canada: North America Cardiovascular Devices Market Breakdown, by Application
- 10.1.1.2.3 Canada: North America Cardiovascular Devices Market Breakdown, by End-User
- 10.1.1.3 Mexico :
North America Cardiovascular Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Mexico : North America Cardiovascular Devices Market Breakdown, by Device
- 10.1.1.3.2 Mexico : North America Cardiovascular Devices Market Breakdown, by Application
- 10.1.1.3.3 Mexico : North America Cardiovascular Devices Market Breakdown, by End-User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Cardiovascular Devices Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Medtronic.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Boston Scientific Corporation.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Abbott.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Jhonson and Jhonson Service Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 General Electric Company.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Koninlijke Philips N.V.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Siemens Healthineers AG.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 BD.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 B.Bruna melsungen AG.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Edwards Lifesciences Corporation.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights